Familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism associated with mutations in the human Ca2+-sensing receptor gene in three Danish families

Scand J Clin Lab Invest. 2000 May;60(3):221-7. doi: 10.1080/003655100750044875.

Abstract

We screened three unrelated Danish families with familial hypocalciuric hypercalcemia (FHH) for mutations in the Ca2+-sensing receptor (CASR) gene by polymerase chain reaction amplification and DNA sequencing of exons 2-7, which include the entire coding region of the gene. In one family the affected individuals have a T-->C mutation that changes the normal arginine at codon 220 to a tryptophan. In the other two FHH families, affected individuals have the same A-->G mutation, leading to conversion of the normal glycine at codon 552 to an arginine. These results confirm that FHH can be caused by non-conservative missense mutations in the CASR gene leading to abnormal calcium homeostasis. Both mutations are located in the amino-terminal extracellular domain of the receptor, which contains the binding site for extracellular Ca2+, the CASR's principal physiological agonist.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Calcium / urine*
  • DNA Mutational Analysis
  • Female
  • Humans
  • Hypercalcemia / genetics*
  • Hypercalcemia / urine*
  • Hyperparathyroidism / genetics*
  • Infant, Newborn
  • Male
  • Mutation*
  • Pedigree
  • Polymerase Chain Reaction
  • Receptors, Calcium-Sensing
  • Receptors, Cell Surface / genetics*
  • Sequence Analysis, DNA

Substances

  • Receptors, Calcium-Sensing
  • Receptors, Cell Surface
  • Calcium